Assembly Biosciences (ASMB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,079 | -6,122 | -28,212 | -19,016 | -8,818 |
| Depreciation Amortization | -763 | -2,217 | -1,421 | -822 | -475 |
| Accounts receivable | 523 | -974 | -912 | N/A | N/A |
| Other Working Capital | -13,575 | -38,279 | -29,560 | -22,343 | -15,077 |
| Other Operating Activity | 797 | 6,499 | 4,775 | 1,984 | 931 |
| Operating Cash Flow | $-22,097 | $-41,093 | $-55,330 | $-40,197 | $-23,439 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -19 | -66 | -42 | N/A | N/A |
| Purchase Of Investment | -62,963 | -229,834 | -218,281 | -37,352 | -19,846 |
| Sale Of Investment | 57,600 | 116,432 | 83,632 | 60,932 | 26,432 |
| Investing Cash Flow | $-5,382 | $-113,468 | $-134,691 | $23,580 | $6,586 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 149 | 169,157 | 174,211 | 2,279 | 1,922 |
| Other Financing Activity | 0 | 5,510 | 0 | 0 | 0 |
| Financing Cash Flow | $149 | $174,667 | $174,211 | $2,279 | $1,922 |
| Beginning Cash Position | 58,450 | 38,344 | 38,344 | 38,344 | 38,344 |
| End Cash Position | 31,120 | 58,450 | 22,534 | 24,006 | 23,413 |
| Net Cash Flow | $-27,330 | $20,106 | $-15,810 | $-14,338 | $-14,931 |
| Free Cash Flow | |||||
| Operating Cash Flow | -22,097 | -41,093 | -55,330 | -40,197 | -23,439 |
| Capital Expenditure | -19 | -66 | -42 | N/A | N/A |
| Free Cash Flow | -22,116 | -41,159 | -55,372 | -40,197 | -23,439 |